【24h】

Immunology of cardiovascular disease.

机译:心血管疾病的免疫学。

获取原文
获取原文并翻译 | 示例
           

摘要

The writings of Russell Ross between the mid 70s and late nineties summarized the remarkable evolution of our thinking about the pathogenesis of atherosclerosis in the late part of the 20th century such that today we talk about the immunology of cardiovascular disease. We have gone from two independent disciplines to the recognition of a remarkable interdigitation of interests. In 1976, the main emphasis was on the response to (endothelial) injury as the main underlying pathogenic mechanism, and on the possible role of hyperlipidemia as the insult leading to endothelial damage [1]. By 1993, Ross emphasized the role of inflammatory processes triggered by endothelial and smooth muscle cell damage [2]. Six years later Ross re-defined atherosclerosis as an inflammatory disease [3]. During those two decades, significant progress had been made in the understanding of the components of the vascular inflammatory reaction. Activated macrophages and T lymphocytes were well represented in atheromatous lesions at all stages of evolution [4-6]. Their contribution to inflammation and tissue damage through mediator release had been accepted as an essential step in the evolution of atherosclerosis. The phenotype of the infiltrating lymphocytes, however, does not fit into the classical Th1-Th2 dichotomy, because the majority seems to produce both interferon-gamma and IL-4, although interferon-gamma appears to be the predominant cytokine produced [7]. In recent years our knowledge about the complexity of regulatory and activation circuits mediated by T lymphocytes and their products has increased exponentially and animal studies suggest that the role of T cells in atherosclerosis is rather complex, as summarized in this issue by Andersson et al. But from the very beginning it was obvious that the involvement of the immune system was not limited to T lymphocyte-mediated inflammation, because immunoglobulins, and late complement components were also detectable in atheromatous lesions and their role the object of speculation [8-10].
机译:罗素·罗斯(Russell Ross)在70年代中期至90年代后期之间的著作总结了我们对20世纪后期动脉粥样硬化发病机理的思考的显着演变,因此今天我们谈论心血管疾病的免疫学。我们已经从两个独立的学科发展为对利益显着交叉的认可。 1976年,主要重点是对(内皮)损伤的反应作为主要的潜在致病机制,并强调高脂血症可能作为导致内皮损伤的损伤[1]。到1993年,罗斯强调了由内皮和平滑肌细胞损伤引发的炎症过程的作用[2]。六年后,罗斯将动脉粥样硬化重新定义为一种炎症性疾病[3]。在这二十年中,在理解血管炎性反应的成分方面取得了重大进展。活化的巨噬细胞和T淋巴细胞在各个发展阶段的动脉粥样硬化病变中都有很好的表现[4-6]。它们通过介质释放对炎症和组织损伤的贡献已被认为是动脉粥样硬化发展的重要步骤。然而,浸润淋巴细胞的表型不适合经典的Th1-Th2二分法,因为大多数似乎都产生干扰素-γ和IL-4,尽管干扰素-γ似乎是主要的细胞因子[7]。近年来,我们对由T淋巴细胞及其产物介导的调节和激活电路的复杂性的了解呈指数增长,动物研究表明,T细胞在动脉粥样硬化中的作用相当复杂,正如Andersson等人在本期杂志中所总结的那样。但是从一开始就很明显,免疫系统的参与不仅限于T淋巴细胞介导的炎症,因为在动脉粥样硬化病变中也可以检测到免疫球蛋白和后期补体成分,并且它们的作用是推测的对象[8-10] 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号